58.86

0.07% -0.04

After Hours: 58.86

Globus Medical Inc (GMED)

Overview News Price History Option Chain Financials Discussions Forecast

Globus Medical Inc stock is traded at $58.86, with a volume of 1.19M. It is down -0.07% in the last 24 hours and down -3.90% over the past month. Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Previous Close:

$58.90

Open:

$59

24h Volume:

1.19M

Relative Volume:

0.82

Market Cap:

$8.17B

Revenue:

$2.51B

Net Income/Loss:

$185.56M

P/E Ratio:

43.93

EPS:

1.34

Net Cash Flow:

$517.59M

1W Performance:

-2.45%

1M Performance:

-3.90%

6M Performance:

-27.96%

1Y Performance:

-10.29%

1-Day Range:

$58.33

$59.40

1-Week Range:

$58.33

$61.74

52-Week Range:

$54.48

$94.93

Globus Medical Inc Stock (GMED) Company Profile

Name

Globus Medical Inc

Sector

Healthcare (1174)

Industry

Medical Devices (149)

Phone

610-930-1800

Address

2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA

Employee

5,300

Twitter

@GlobusMedical

Next Earnings Date

2024-11-05

Latest SEC Filings

GMED's Discussions on Twitter

Compare GMED with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GMED Globus Medical Inc	58.86	8.17B	2.51B	185.56M	517.59M	1.34
ABT Abbott Laboratories	134.01	232.09B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	101.49	148.00B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	377.12	146.09B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	87.92	112.11B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	74.82	44.79B	5.54B	4.18B	623.10M	7.00

Globus Medical Inc Stock (GMED) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-27-25	Downgrade	BTIG Research	Buy → Neutral
Jan-10-25	Upgrade	BofA Securities	Underperform → Neutral
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-07-24	Upgrade	Wells Fargo	Equal Weight → Overweight
May-20-24	Upgrade	Piper Sandler	Neutral → Overweight
Mar-18-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	ROTH MKM	Buy
Sep-19-23	Upgrade	Stifel	Hold → Buy
Mar-30-23	Upgrade	Canaccord Genuity	Hold → Buy
Feb-13-23	Downgrade	BofA Securities	Buy → Underperform
Feb-10-23	Downgrade	BTIG Research	Buy → Neutral
Feb-10-23	Downgrade	Loop Capital	Buy → Hold
Feb-10-23	Downgrade	Needham	Buy → Hold
Feb-10-23	Downgrade	Truist	Buy → Hold
Feb-10-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Buy
Apr-13-22	Resumed	Truist	Buy
Mar-28-22	Initiated	Wells Fargo	Overweight
Jan-04-22	Upgrade	Piper Sandler	Neutral → Overweight
Dec-13-21	Upgrade	BofA Securities	Underperform → Buy
Dec-10-21	Initiated	RBC Capital Mkts	Outperform
Oct-29-21	Initiated	Loop Capital	Buy
Feb-18-21	Resumed	Needham	Buy
Dec-08-20	Initiated	Citigroup	Buy
Oct-20-20	Initiated	Stifel	Hold
Aug-06-20	Reiterated	Needham	Buy
Aug-06-20	Upgrade	Northland Capital	Market Perform → Outperform
Jul-21-20	Initiated	Northland Capital	Market Perform
Jul-06-20	Downgrade	Piper Sandler	Overweight → Neutral
May-08-20	Reiterated	Needham	Buy
Mar-18-20	Upgrade	BTIG Research	Neutral → Buy
Jan-08-20	Initiated	SunTrust	Buy
Dec-12-19	Upgrade	Wells Fargo	Market Perform → Outperform
Aug-02-19	Reiterated	Needham	Buy
May-24-19	Downgrade	Wells Fargo	Outperform → Market Perform
May-03-19	Reiterated	Needham	Buy
Feb-28-19	Upgrade	UBS	Neutral → Buy
Jan-02-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-02-18	Reiterated	Needham	Buy
Jun-27-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jun-01-18	Initiated	Cantor Fitzgerald	Overweight
May-03-18	Reiterated	Needham	Buy
Apr-04-18	Upgrade	Needham	Hold → Buy

View All

Globus Medical Inc Stock (GMED) Latest News

Jun 15, 2025

Globus Medical Announces $500M Share Repurchase Program to Boost Shareholder Value - MSN

Jun 15, 2025

Is Globus Medical, Inc.'s (NYSE:GMED) Recent Price Movement Underpinned By Its Weak Fundamentals? - simplywall.st

Jun 15, 2025

Jun 12, 2025

Globus Medical’s SWOT analysis: robotic spine leader’s stock poised for growth By Investing.com - Investing.com South Africa

Jun 12, 2025

Globus Medical’s SWOT analysis: robotic spine leader’s stock poised for growth - Investing.com

Jun 12, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc.GMED - PR Newswire

Jun 12, 2025

Jun 11, 2025

Medical Devices & SuppliesSpecialty Stocks Q1 Recap: Benchmarking Globus Medical (NYSE:GMED) - Yahoo Finance

Jun 11, 2025

Globus Medical, Inc. (NYSE:GMED) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jun 11, 2025

Jun 10, 2025

Globus Medical (GMED) Poised for Growth Despite Recent Challenge - GuruFocus

Jun 10, 2025

Parallel Advisors LLC Purchases 193 Shares of Globus Medical, Inc. (NYSE:GMED) - Defense World

Jun 10, 2025

Jun 09, 2025

Total Disc Replacement Market Detailed in New Report - openPR.com

Jun 09, 2025

GAMMA Investing LLC Raises Position in Globus Medical, Inc. (NYSE:GMED) - Defense World

Jun 09, 2025

Jun 06, 2025

Collegeville Office Buildings Sell to Globus Medical with Staggering Price Cut - VISTA.Today

Jun 06, 2025

Jun 05, 2025

Globus Medical Approves Key Proposals at Annual Meeting - TipRanks

Jun 05, 2025

Intuitive Surgical's da Vinci 5: Gaining Precision, Power and Potential - Yahoo Finance

Jun 05, 2025

Jun 04, 2025

Adult Spinal Deformity Market Detailed in New Research Report - openPR.com

Jun 04, 2025

Jun 03, 2025